Shared Care Protocol – June 2025

Documents
-
KMICB amiodarone for patients within adult services June 2025 V1
-
KMICB Apomorphine for use in Adult Services SCP June 2025 V1
-
KMICB azathioprine & mercaptopurine for pts within adult services non transplant June 2025 V1
-
KMICB ciclosporin oral for patients within adult services non transplant indications June 2025 V1
-
KMICB D-Penicillamine for use as a DMARD SCP June 2025 V1
-
KMICB Dapsone for use as a disease-modifying anti-rheumatic drug (DMARD) SCP June 2025 V1
-
KMICB Denosumab Shared Care Protocol June 2025 V1
-
KMICB dronedarone for patients in adult services June 2025 V1
-
KMICB Hydroxycarbamide for myeloproliferative disorders-sickle cell disease for pts in adults June 2025 V1
-
KMICB hydroxychloroquine for patients within adult- ervices June 2025 V1
-
KMICB leflunomide for patients within adult services June 2025 V1
-
KMICB lithium for patients within adult services June 2025 V1
-
KMICB methotrexate oral and subcutaneous for patients in adult services excluding cancer care June 2025 V1
-
KMICB mycophenolate mofetil & mycophenolic acid for non transplant June 2025 V1
-
KMICB Oral Liothyronine for Adult Patients with Hypothyroidism SCP June 2025 V1
-
KMICB Rifaximin for the treatment of Hepatic Encephalopathy (HE) SCP June 2025 V1
-
KMICB riluzole for patients within adult services June 2025 V1
-
KMICB Sativex oromucosal spray for treatment of spasticity in patients with MS SCP June 2025 V1
-
KMICB sulfasalazine for patients within adult services June 2025 V1
-
KMICB Tacrolimus for use as a DMARD SCP June 2025 V1

